Systemic therapy of early breast cancer (CROSBI ID 294881)
Prilog u časopisu | pregledni rad (stručni)
Podaci o odgovornosti
Šeparović, Robert ; Silovski, Tajana ; Zorica, Robert ; Pavlović, Mirjana ; Vazdar, Ljubica ; Pavlica, Vesna
engleski
Systemic therapy of early breast cancer
Breast cancer is the most common cancer in women. Early breast cancer is potentially curable disease. Systemic adjuvant therapy is created to treat micrometastatic disease or destroy breast cancer cells that have spread from the breast and regional lymph nodes, but have not yet formed visible distant metastases. Systemic adjuvant therapy is based on chemotherapy with or without targeted therapy, and endocrine therapy, sometimes in combination with adjuvant irradiation, usually is conducted after surgery. The aim of adjuvant therapy is to decrease recurrence rate and extension of overall survival
breast cancer ; micrometastasis ; adjuvant chemotherapy ; biological therapy ; survival rate
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano